Concourse Financial Group Securities, Inc. Biotechnology

Concourse Financial Group Securities, Inc.

$0
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
IBRX Immunity Bio, Inc.	$1.16B	$0 100.0% of portfolio	0	Q1 2025 New
IMCR Immunocore Holdings PLC	$1.67B	$0 100.0% of portfolio	0	Q1 2025 New
IMNM Immunome Inc.	$112M	$0 100.0% of portfolio	0	Q1 2025 New
IPA Immuno Precise Antibodies Ltd.	$13.7M	$0 100.0% of portfolio	0	Q1 2025 New
IMVT Immunovant, Inc.	$3.55B	$0 100.0% of portfolio	0	Q1 2025 New
IMRN Immuron Limited	$11.8M	$0 100.0% of portfolio	-	Q1 2025 New
IMMP Immutep LTD	$162M	$0 100.0% of portfolio	0	Q1 2025 New
INAB In8 Bio, Inc.	$2.94M	$0 100.0% of portfolio	0	Q1 2025 New
INCY Incyte Corp	$15B	$0 100.0% of portfolio	0	Q1 2025 Sold Out
INDP Indaptus Therapeutics, Inc.	$2.89M	$0 100.0% of portfolio	0	Q1 2025 New
IFRX Infla Rx N.V.	$37.6M	$0 100.0% of portfolio	0	Q1 2025 New
INMB Inmune Bio, Inc.	$138M	$0 100.0% of portfolio	0	Q1 2025 New
IPHA Innate Pharma Sa	$174M	$0 100.0% of portfolio	0	Q1 2025 New
INVA Innoviva, Inc.	$1.48B	$0 100.0% of portfolio	0	Q1 2025 New
INZY Inozyme Pharma, Inc.	$160M	$0 100.0% of portfolio	0	Q1 2025 New
INSM Insmed Inc	$9.85B	$0 100.0% of portfolio	0	Q1 2025 New
NTLA Intellia Therapeutics, Inc.	$576M	$0 100.0% of portfolio	0	Q1 2025 Sold Out
IVA Inventiva S.A.	$150M	$0 100.0% of portfolio	0	Q1 2025 New
IOBT Io Biotech, Inc.	$44.7M	$0 100.0% of portfolio	0	Q1 2025 New
IONS Ionis Pharmaceuticals Inc	$5B	$0 100.0% of portfolio	0	Q1 2025 New
IOVA Iovance Biotherapeutics, Inc.	$284M	$0 100.0% of portfolio	0	Q1 2025 New
ITOS I Teos Therapeutics, Inc.	$362M	$0 100.0% of portfolio	0	Q1 2025 New
JAGX Jaguar Health, Inc.	$500M	$0 100.0% of portfolio	0	Q1 2025 New
JANX Janux Therapeutics, Inc.	$1.03B	$0 100.0% of portfolio	0	Q1 2025 New
JAZZ Jazz Pharmaceuticals PLC	$6.82B	$0 100.0% of portfolio	0	Q1 2025 Sold Out
KALV Kal Vista Pharmaceuticals, Inc.	$345M	$0 100.0% of portfolio	0	Q1 2025 New
KMPH Kempharm, Inc	$170M	$0 100.0% of portfolio	0	Q1 2025 New
KROS Keros Therapeutics, Inc.	$389M	$0 100.0% of portfolio	0	Q1 2025 New
KRBP Kiromic Biopharma, Inc.	$1.74M	$0 100.0% of portfolio	0	Q1 2025 New
KOD Kodiak Sciences Inc.	$204M	$0 100.0% of portfolio	0	Q1 2025 New
KRON Kronos Bio, Inc.	$49.4M	$0 100.0% of portfolio	0	Q1 2025 New
KRYS Krystal Biotech, Inc.	$3.4B	$0 100.0% of portfolio	0	Q1 2025 New
KURA Kura Oncology, Inc.	$439M	$0 100.0% of portfolio	0	Q1 2025 New
KYMR Kymera Therapeutics, Inc.	$2.61B	$0 100.0% of portfolio	0	Q1 2025 New
LTRN Lantern Pharma Inc.	$35M	$0 100.0% of portfolio	0	Q1 2025 New
LRMR Larimar Therapeutics, Inc.	$104M	$0 100.0% of portfolio	0	Q1 2025 New
LVTX Lava Therapeutics Nv	$33.3M	$0 100.0% of portfolio	0	Q1 2025 New
LEGN Legend Biotech Corp	$5.27B	$0 100.0% of portfolio	0	Q1 2025 New
LEXX Lexaria Bioscience Corp.	$5.47M	$0 100.0% of portfolio	0	Q1 2025 New
LXRX Lexicon Pharmaceuticals, Inc.	$140M	$0 100.0% of portfolio	0	Q1 2025 New
LGND Ligand Pharmaceuticals Inc	$1.76B	$0 100.0% of portfolio	0	Q1 2025 Sold Out
LMNL Liminal Bio Sciences Inc.	$0	$0 100.0% of portfolio	0	Q1 2025 New
LCTX Lineage Cell Therapeutics, Inc.	$112M	$0 100.0% of portfolio	0	Q1 2025 New
LQDA Liquidia Corp	$1.18B	$0 100.0% of portfolio	0	Q1 2025 New
LYEL Lyell Immunopharma, Inc.	$2.84B	$0 100.0% of portfolio	0	Q1 2025 New
LYRA Lyra Therapeutics, Inc.	$951M	$0 100.0% of portfolio	0	Q1 2025 New
MGNX Macrogenics Inc	$107M	$0 100.0% of portfolio	0	Q1 2025 New
MDGL Madrigal Pharmaceuticals, Inc.	$4.69B	$0 100.0% of portfolio	0	Q1 2025 Sold Out
MAIA Maia Biotechnology, Inc.	$19.1M	$0 100.0% of portfolio	0	Q1 2025 New
MNKD Mannkind Corp	$1.11B	$0 100.0% of portfolio	0	Q1 2025 Sold Out

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.